CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 74 filers reported holding CATALYST BIOSCIENCES INC in Q2 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $58,000 | -21.6% | 16,710 | -4.0% | 0.02% | -46.7% |
| Q2 2021 | $74,000 | -10.8% | 17,410 | -2.2% | 0.03% | +15.4% |
| Q1 2021 | $83,000 | -25.9% | 17,810 | 0.0% | 0.03% | -45.8% |
| Q4 2020 | $112,000 | +41.8% | 17,810 | 0.0% | 0.05% | +37.1% |
| Q3 2020 | $79,000 | -26.2% | 17,810 | -2.7% | 0.04% | -22.2% |
| Q2 2020 | $107,000 | +24.4% | 18,310 | -5.2% | 0.04% | +18.4% |
| Q1 2020 | $86,000 | -28.9% | 19,310 | +5.5% | 0.04% | -13.6% |
| Q4 2019 | $121,000 | +34.4% | 18,310 | 0.0% | 0.04% | +22.2% |
| Q3 2019 | $90,000 | -29.1% | 18,310 | +5.8% | 0.04% | -37.9% |
| Q2 2019 | $127,000 | -2.3% | 17,310 | +7.3% | 0.06% | -31.0% |
| Q1 2019 | $130,000 | -11.6% | 16,131 | -11.9% | 0.08% | +16.7% |
| Q4 2018 | $147,000 | -18.3% | 18,310 | +5.8% | 0.07% | -25.8% |
| Q3 2018 | $180,000 | -26.2% | 17,310 | +103.6% | 0.10% | -12.6% |
| Q2 2018 | $244,000 | +9.9% | 8,500 | -29.8% | 0.11% | +6.7% |
| Q4 2017 | $222,000 | – | 12,100 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |